Search

everythinglearnresearchcommunity

for

Search:↓

A clinically suspected melanoma appeared benign under the microscope but was confirmed by specific tests and a rare mutation.

BAP1 mutations are rare in pediatric melanocytic tumors and may develop later in life.

The document concludes that the immune-inhibitory environment of the hair follicle may prevent melanoma development.

A woman's long-term scalp issues were diagnosed as a rare skin disorder called cutaneous Langerhans cell histiocytosis.

Thymic LCH may be underdiagnosed, so thymic ultrasound should be considered in infants with cutaneous LCH.

Moles may stop growing due to cell cooperation, not just because of individual cell aging.

Moles may stop growing because of cell cooperation, not just because of aging cells.

Scalp melanoma is more common and easier to diagnose early in people with androgenetic alopecia due to sun damage.

Keratinocytes can reverse the effects of the GNAQ oncogene, inhibiting melanoma cell growth.

Targeting multiple pathways and understanding genetic mutations are crucial for effective melanoma therapy.

The microenvironment affects the behavior and survival of melanocytes with the GNAQ oncogene in melanoma.

The combination treatment showed a higher response rate but no significant survival benefits.

Keratinocytes can reduce the survival of certain melanoma cells, suggesting new therapy paths.

Scalp melanoma, a deadly skin cancer, is often found late due to its hard-to-see location, especially in older men. Early detection, possible treatments, and the role of hairdressers in spotting it early are discussed. More research is needed to improve detection and treatment.

Stopping mitochondrial respiration can prevent brain cancer spread in skin cancer patients, and plant compound β-sitosterol could help achieve this.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

Biological therapy boosts the immune system to effectively fight melanoma.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Male hair loss is mainly due to thinner hair, not less hair.

Hair follicles protect melanocytes from sun damage, helping them replenish skin.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

Cancer treatments often cause skin, nail, and hair problems.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.